The most promising post-translational modification in ESE-1 is phosphorylation, where ESE-1 has previously been shown to be stabilized by serine phosphorylation, which altered its subcellular localization and protein half-life in breast cancer (Manavathi et al., 2007). Here, ELF3 is linked to breast cancer.